{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:40:29Z","timestamp":1787586029924,"version":"build-2736575974"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015570","name":"Northwest Fisheries Science Center","doi-asserted-by":"publisher","award":["51903202"],"award-info":[{"award-number":["51903202"]}],"id":[{"id":"10.13039\/100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015570","name":"Northwest Fisheries Science Center","doi-asserted-by":"publisher","award":["81874239"],"award-info":[{"award-number":["81874239"]}],"id":[{"id":"10.13039\/100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015570","name":"Northwest Fisheries Science Center","doi-asserted-by":"publisher","award":["51573129"],"award-info":[{"award-number":["51573129"]}],"id":[{"id":"10.13039\/100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015570","name":"Northwest Fisheries Science Center","doi-asserted-by":"publisher","award":["51873179"],"award-info":[{"award-number":["51873179"]}],"id":[{"id":"10.13039\/100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015570","name":"Northwest Fisheries Science Center","doi-asserted-by":"publisher","award":["82073422"],"award-info":[{"award-number":["82073422"]}],"id":[{"id":"10.13039\/100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015570","name":"Northwest Fisheries Science Center","doi-asserted-by":"publisher","award":["81903240"],"award-info":[{"award-number":["81903240"]}],"id":[{"id":"10.13039\/100015570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["19\/IFA\/7435"],"award-info":[{"award-number":["19\/IFA\/7435"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["GOIPD\/2019\/861"],"award-info":[{"award-number":["GOIPD\/2019\/861"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.addr.2021.113842","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T01:28:40Z","timestamp":1626744520000},"page":"113842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Highly branched poly(\u03b2-amino ester)s for gene delivery in hereditary skin diseases"],"prefix":"10.1016","volume":"176","author":[{"given":"Ming","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezhong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigen","family":"A","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Alshehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Lara-S\u00e1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3053-2756","authenticated-orcid":false,"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3685-4548","authenticated-orcid":false,"given":"Wenxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2021.113842_b0005","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.113842_b0010","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nrg2971","article-title":"State-of-the-art gene-based therapies: the road ahead","volume":"12","author":"Kay","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.addr.2021.113842_b0015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.addr.2021.113842_b0020","doi-asserted-by":"crossref","unstructured":"M. Ramamoorth, A. Narvekar, Non viral vectors in gene therapy- an overview, J. Clin. Diagn Res. 2015;9:GE01-6.","DOI":"10.7860\/JCDR\/2015\/10443.5394"},{"key":"10.1016\/j.addr.2021.113842_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2015.12.012","article-title":"Non-viral gene therapy: Gains and challenges of non-invasive administration methods","volume":"240","author":"Foldvari","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd1775","article-title":"Design and development of polymers for gene delivery","volume":"4","author":"Pack","year":"2005","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.addr.2021.113842_b0035","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.drudis.2013.06.014","article-title":"Polymer gene delivery: overcoming the obstacles","volume":"18","author":"Aied","year":"2013","journal-title":"Drug. Discov. Today"},{"key":"10.1016\/j.addr.2021.113842_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2796.2002.00995.x","article-title":"Cutaneous gene transfer for skin and systemic diseases","volume":"252","author":"Khavari","year":"2002","journal-title":"J. Int. Med."},{"key":"10.1016\/j.addr.2021.113842_b0045","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1016\/j.vaccine.2015.05.012","article-title":"Recent insights into cutaneous immunization: how to vaccinate via the skin","volume":"33","author":"Engelke","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.113842_b0050","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015149","article-title":"Gene therapy for skin diseases","volume":"4","author":"Gorell","year":"2014","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.addr.2021.113842_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jgm.3089","article-title":"Transcutaneous delivery of DNA\/mRNA for cancer therapeutic vaccination","volume":"21","author":"Sun","year":"2019","journal-title":"J. Gene Med."},{"key":"10.1016\/j.addr.2021.113842_b0060","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201801359","article-title":"Poly(\u03b2-amino esters): synthesis, formulations, and their biomedical applications","volume":"8","author":"Liu","year":"2019","journal-title":"Adv. Healthc Mater."},{"key":"10.1016\/j.addr.2021.113842_b0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2019.08.024","article-title":"Poly(\u03b2-amino ester)-based gene delivery systems: from discovery to therapeutic applications","volume":"310","author":"Cordeiro","year":"2019","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0070","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/jid.1962.156","article-title":"Studies on the pathogenesis of epidermolysis bullosa","volume":"39","author":"Pearson","year":"1962","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0075","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.matbio.2018.04.001","article-title":"Epidermolysis bullosa: Molecular pathology of connective tissue components in the cutaneous basement membrane zone","volume":"71\u201372","author":"Has","year":"2018","journal-title":"Matrix. Biol."},{"key":"10.1016\/j.addr.2021.113842_b0080","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0085","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/jamadermatol.2015.5237","article-title":"Genotypic heterogeneity and the mode of inheritance in epidermolysis bullosa","volume":"152","author":"Uitto","year":"2016","journal-title":"JAMA Dermatology"},{"key":"10.1016\/j.addr.2021.113842_b0090","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5582\/irdr.2017.01005","article-title":"Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Rashidghamat","year":"2017","journal-title":"Intractable rare Dis. Res."},{"key":"10.1016\/j.addr.2021.113842_b0095","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1046\/j.1523-1747.2003.12571.x","article-title":"Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce Type VII collagen at the basement membrane zone","volume":"121","author":"Woodley","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJMcibr1414709","article-title":"A biologic velcro patch","volume":"372","author":"Tolar","year":"2015","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.addr.2021.113842_b0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jaad.2009.03.053","article-title":"Extracutaneous manifestations and complications of inherited epidermolysis bullosa. Part II. Other organs","volume":"61","author":"Fine","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaad.2008.09.035","article-title":"Epidermolysis bullosa and the risk of life-threatening cancers: the national EB registry experience, 1986\u20132006","volume":"60","author":"Fine","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1523-1747.2001.01279-11.x","article-title":"Epidermolysis bullosa carrier frequencies in the US population","volume":"116","author":"Pfendner","year":"2001","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0120","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2009.06.011","article-title":"Life with epidermolysis bullosa (EB): Etiology, diagnosis, multidisciplinary care and therapy","volume":"61","author":"Murrell","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0125","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jid.2017.12.016","article-title":"EB2017\u2014progress in epidermolysis bullosa research toward treatment and cure","volume":"138","author":"Uitto","year":"2018","journal-title":"J. Invest. Dermatol"},{"key":"10.1016\/j.addr.2021.113842_b0130","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.15252\/emmm.201505061","article-title":"Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms","volume":"7","author":"Nystrom","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.addr.2021.113842_b0135","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0140","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaad.2013.08.014","article-title":"A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa","volume":"69","author":"Venugopal","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0145","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.addr.2021.113842_b0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.addr.2021.113842_b0155","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1038\/jid.2015.158","article-title":"Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa","volume":"135","author":"Petrof","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0160","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/mt.2015.58","article-title":"High local concentrations of intradermal MSCs restore skin integrity and facilitate wound healing in dystrophic epidermolysis bullosa","volume":"23","author":"K\u00fchl","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0165","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/jid.2015.149","article-title":"Recessive dystrophic epidermolysis bullosa: advances in the laboratory leading to new therapies","volume":"135","author":"Woodley","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/mt.2008.234","article-title":"Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa","volume":"17","author":"Remington","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0175","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/mt.2013.87","article-title":"Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure","volume":"21","author":"Wang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0180","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1038\/jid.2013.10","article-title":"Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosa","volume":"133","author":"Woodley","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2008.262","article-title":"Can type VII collagen injections cure dystrophic epidermolysis bullosa?","volume":"17","author":"Bruckner-Tuderman","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0190","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1172\/JCI92707","article-title":"Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients","volume":"127","author":"Woodley","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2021.113842_b0195","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.19","article-title":"Gene editing for the efficient correction of a recurrent COL7A1 mutation in recessive dystrophic epidermolysis bullosa keratinocytes","volume":"5","author":"Chamorro","year":"2016","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"10.1016\/j.addr.2021.113842_b0200","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.ymthe.2017.07.005","article-title":"COL7A1 editing via CRISPR\/Cas9 in recessive dystrophic epidermolysis bullosa","volume":"25","author":"Hainzl","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0205","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jama.2016.15588","article-title":"Safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive dystrophic epidermolysis bullosa","volume":"316","author":"Siprashvili","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.addr.2021.113842_b0210","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrg1066","article-title":"Progress and problems with the use of viral vectors for gene therapy","volume":"4","author":"Thomas","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.addr.2021.113842_b0215","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.addr.2021.113842_b0220","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1016\/j.jid.2016.07.029","article-title":"Targeted exon skipping restores type VII collagen expression and anchoring fibril formation in an in vivo RDEB model","volume":"136","author":"Turczynski","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0225","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0230","doi-asserted-by":"crossref","first-page":"10761","DOI":"10.1021\/ja0015388","article-title":"Degradable poly(\u03b2-amino esters): synthesis, characterization, and self-assembly with plasmid DNA","volume":"122","author":"Lynn","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2021.113842_b0235","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/anie.200351244","article-title":"Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery","volume":"42","author":"Anderson","year":"2003","journal-title":"Angew Chemie Int. Ed."},{"key":"10.1016\/j.addr.2021.113842_b0240","doi-asserted-by":"crossref","first-page":"5316","DOI":"10.1021\/ja034429c","article-title":"Parallel synthesis and biophysical characterization of a degradable polymer library for gene delivery","volume":"125","author":"Akinc","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2021.113842_b0245","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/bc034067y","article-title":"Synthesis of poly(\u03b2-amino ester)s optimized for highly effective gene delivery","volume":"14","author":"Akinc","year":"2003","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.addr.2021.113842_b0250","doi-asserted-by":"crossref","first-page":"16028","DOI":"10.1073\/pnas.0407218101","article-title":"A polymer library approach to suicide gene therapy for cancer","volume":"101","author":"Anderson","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2021.113842_b0255","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ymthe.2004.11.015","article-title":"Structure\/property studies of polymeric gene delivery using a library of poly(\u03b2-amino esters)","volume":"11","author":"Anderson","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0260","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.mt.6300132","article-title":"Rapid optimization of gene delivery by parallel end-modification of poly(\u03b2-amino ester)s","volume":"15","author":"Zugates","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0265","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1002\/adma.200700371","article-title":"Combinatorial modification of degradable polymers enables transfection of human cells comparable to adenovirus","volume":"19","author":"Green","year":"2007","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2021.113842_b0270","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1021\/bc7002082","article-title":"Gene delivery properties of end-modified poly(\u03b2-amino ester)s","volume":"18","author":"Zugates","year":"2007","journal-title":"Bioconjug Chem."},{"key":"10.1016\/j.addr.2021.113842_b0275","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1158\/0008-5472.CAN-09-0061","article-title":"Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice","volume":"69","author":"Huang","year":"2009","journal-title":"Can. Res."},{"key":"10.1016\/j.addr.2021.113842_b0280","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1016\/j.biomaterials.2010.07.023","article-title":"The relationship between terminal functionalization and molecular weight of a gene delivery polymer and transfection efficacy in mammary epithelial 2-D cultures and 3-D organotypic cultures","volume":"31","author":"Bhise","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113842_b0285","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1016\/j.biomaterials.2011.04.016","article-title":"Non-viral gene delivery nanoparticles based on poly(\u03b2-amino esters) for treatment of glioblastoma","volume":"32","author":"Tzeng","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113842_b0290","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1016\/j.biomaterials.2012.01.046","article-title":"Effect of molecular weight of amine end-modified poly(\u03b2-amino ester)s on gene delivery efficiency and toxicity","volume":"33","author":"Eltoukhy","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113842_b0295","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/smll.201101718","article-title":"A novel assay for quantifying the number of plasmids encapsulated by polymer nanoparticles","volume":"8","author":"Bhise","year":"2012","journal-title":"Small"},{"key":"10.1016\/j.addr.2021.113842_b0300","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1021\/mp3004176","article-title":"Uptake and transfection with polymeric nanoparticles are dependent on polymer end-group structure, but largely independent of nanoparticle physical and chemical properties","volume":"9","author":"Sunshine","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2021.113842_b0305","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/nn501197v","article-title":"Biodegradable polymeric nanoparticles show high efficacy and specificity at DNA delivery to human glioblastoma in vitro and in vivo","volume":"8","author":"Guerrero-C\u00e1zares","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2021.113842_b0310","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1021\/nn504905q","article-title":"Polymeric nanoparticles for nonviral gene therapy extend brain tumor survival in vivo","volume":"9","author":"Mangraviti","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2021.113842_b0315","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/adma.201204346","article-title":"Degradable terpolymers with alkyl side chains demonstrate enhanced gene delivery potency and nanoparticle stability","volume":"25","author":"Eltoukhy","year":"2013","journal-title":"Adv Mater"},{"key":"10.1016\/j.addr.2021.113842_b0320","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jconrel.2013.01.019","article-title":"DNA delivery with hyperbranched polylysine: a comparative study with linear and dendritic polylysine","volume":"169","author":"Kadlecova","year":"2013","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0325","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1002\/anie.201402341","article-title":"Significance of branching for transfection: synthesis of highly branched degradable functional poly(dimethylaminoethyl methacrylate) by vinyl oligomer combination","volume":"53","author":"Zhao","year":"2014","journal-title":"Angew Chemie \u2013 Int. Ed."},{"key":"10.1016\/j.addr.2021.113842_b0330","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1016\/j.biomaterials.2012.02.015","article-title":"The effect of molecular weight, compositions and lectin type on the properties of hyperbranched glycopolymers as non-viral gene delivery systems","volume":"33","author":"Ahmed","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2021.113842_b0335","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1021\/ja005715g","article-title":"Cationic hyperbranched poly(amino ester): a novel class of DNA condensing molecule with cationic surface, biodegradable three-dimensional structure, and tertiary amine groups in the interior","volume":"123","author":"Lim","year":"2001","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2021.113842_b0340","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1039\/b309487a","article-title":"Novel poly(amino ester)s obtained from michael addition polymerizations of trifunctional amine monomers with diacrylates: safe and efficient DNA carriers","volume":"20","author":"Liu","year":"2003","journal-title":"Chem. Commun. (Camb)"},{"key":"10.1016\/j.addr.2021.113842_b0345","doi-asserted-by":"crossref","first-page":"8473","DOI":"10.1039\/C5CC02193F","article-title":"Tailoring highly branched poly(\u03b2-amino ester)s: a synthetic platform for epidermal gene therapy","volume":"51","author":"Huang","year":"2015","journal-title":"Chem. Commun."},{"issue":"11","key":"10.1016\/j.addr.2021.113842_b0350","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1021\/acs.biomac.6b01120","article-title":"Highly branched poly(\u03b2-amino esters) for non-viral gene delivery: high transfection efficiency and low toxicity achieved by increasing molecular weight","volume":"17","author":"Gao","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2021.113842_b0355","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1600102","article-title":"The transition from linear to highly branched poly(\u03b2-amino ester)s: branching matters for gene delivery","volume":"2","author":"Zhou","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2021.113842_b0360","doi-asserted-by":"crossref","unstructured":"D. Zhou, Y. Gao, J. O\u2019Keeffe Ahern, A S, Q. Xu, X. Huang, et al., Development of Branched Poly(5-Amino-1-pentanol- co -1,4-butanediol Diacrylate) with High Gene Transfection Potency Across Diverse Cell Types, ACS Appl Mater Interfaces 2016;8:34218\u201334226.","DOI":"10.1021\/acsami.6b12078"},{"key":"10.1016\/j.addr.2021.113842_b0365","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3390\/polym9050161","article-title":"Highly branched poly(5-amino-1-pentanol-co-1,4-butanediol diacrylate) for high performance gene transfection","volume":"9","author":"Zeng","year":"2017","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.addr.2021.113842_b0370","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1021\/acs.nanolett.8b04098","article-title":"Manipulation of transgene expression in fibroblast cells by a multifunctional linear-branched hybrid poly(\u03b2-amino ester) synthesized through an oligomer combination approach","volume":"19","author":"Zeng","year":"2019","journal-title":"Nano Lett"},{"key":"10.1016\/j.addr.2021.113842_b0375","doi-asserted-by":"crossref","first-page":"30661","DOI":"10.1021\/acsami.9b13135","article-title":"Efficient and robust highly branched poly(\u03b2-amino ester)\/minicircle COL7A1 polymeric nanoparticles for gene delivery to recessive dystrophic epidermolysis bullosa keratinocytes","volume":"11","author":"Zeng","year":"2019","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.addr.2021.113842_b0380","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0378-1119(88)90610-5","article-title":"Transfection of primary human skin fibroblasts by electroporation","volume":"68","author":"Fountain","year":"1988","journal-title":"Gene"},{"key":"10.1016\/j.addr.2021.113842_b0385","first-page":"328","article-title":"Optimizing electroporation conditions in primary and other difficult-to-transfect cells","volume":"19","author":"Jordan","year":"2008","journal-title":"J. Biomol. Tech."},{"key":"10.1016\/j.addr.2021.113842_b0390","first-page":"438","article-title":"Evaluating electroporation and lipofectamine approaches for transient and stable transgene expressions in human fibroblasts and embryonic stem cells","volume":"17","author":"Sharifi Tabar","year":"2015","journal-title":"Cell J."},{"key":"10.1016\/j.addr.2021.113842_b0395","first-page":"1","article-title":"Inhaled nanoformulated mRNA polyplexes for protein production in lung epithelium","volume":"31","author":"Patel","year":"2019","journal-title":"Adv Mater"},{"key":"10.1016\/j.addr.2021.113842_b0400","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1254\/jphs.14R10CP","article-title":"Therapeutic potential of human adipose-derived stem cells in neurological disorders","volume":"126","author":"Chang","year":"2014","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.addr.2021.113842_b0405","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1073\/pnas.0905432106","article-title":"Genetic engineering of human stem cells for enhanced angiogenesis using biodegradable polymeric nanoparticles","volume":"107","author":"Yang","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2021.113842_b0410","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coph.2003.09.006","article-title":"Stem cells as a potential treatment of neurological disorders","volume":"4","author":"Tai","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.addr.2021.113842_b0415","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1038\/s41467-019-11190-0","article-title":"Highly branched poly(\u03b2-amino ester) delivery of minicircle DNA for transfection of neurodegenerative disease related cells","volume":"10","author":"Liu","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2021.113842_b0420","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1016\/j.vaccine.2010.03.040","article-title":"Biosafety of DNA vaccines: new generation of DNA vectors and current knowledge on the fate of plasmids after injection","volume":"28","author":"Faurez","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2021.113842_b0425","doi-asserted-by":"crossref","first-page":"23125","DOI":"10.1038\/srep23125","article-title":"Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer","volume":"6","author":"Munye","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.addr.2021.113842_b0430","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/sj.gt.3300540","article-title":"A new DNA vehicle for nonviral gene delivery: supercoiled minicircle","volume":"4","author":"Darquet","year":"1997","journal-title":"Gene Ther"},{"key":"10.1016\/j.addr.2021.113842_b0435","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.gt.3300816","article-title":"Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer","volume":"6","author":"Darquet","year":"1999","journal-title":"Gene Ther"},{"key":"10.1016\/j.addr.2021.113842_b0440","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1517\/14712598.2015.996544","article-title":"Minicircle DNA vectors for gene therapy: advances and applications","volume":"15","author":"Gaspar","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0445","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1006\/mthe.2001.0278","article-title":"Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver","volume":"3","author":"Chen","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0450","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/sj.gt.3302231","article-title":"Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo","volume":"11","author":"Chen","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2021.113842_b0455","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S1525-0016(03)00168-0","article-title":"Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo","volume":"8","author":"Chen","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0460","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s11095-008-9778-x","article-title":"Sonoporation of the minicircle-VEGF165 for wound healing of diabetic mice","volume":"26","author":"Yoon","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2021.113842_b0465","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jgm.2618","article-title":"Effective healing of diabetic skin wounds by using nonviral gene therapy based on minicircle vascular endothelial growth factor DNA and a cationic dendrimer","volume":"14","author":"Kwon","year":"2012","journal-title":"J. Gene Med."},{"key":"10.1016\/j.addr.2021.113842_b0470","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.4161\/hv.28077","article-title":"Safety and efficacy of DNA vaccines","volume":"10","author":"Stenler","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.addr.2021.113842_b0475","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jconrel.2007.10.014","article-title":"Efficient expression of vascular endothelial growth factor using minicircle DNA for angiogenic gene therapy","volume":"125","author":"Chang","year":"2008","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0480","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1038\/srep05961","article-title":"A new strategy to deliver synthetic protein drugs: self-reproducible biologics using minicircles","volume":"4","author":"Yi","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2021.113842_b0485","first-page":"1","article-title":"Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma","volume":"2014","author":"Chang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.addr.2021.113842_b0490","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/exd.13054","article-title":"A non-viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa","volume":"25","author":"Cutlar","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0495","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.carres.2006.05.024","article-title":"Physicochemical properties and antitumor activities of water-soluble native and sulfated hyperbranched mushroom polysaccharides","volume":"341","author":"Tao","year":"2006","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.addr.2021.113842_b0500","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/acs.biomac.5b00966","article-title":"Highly branched poly(\u03b2-amino esters): synthesis and application in gene delivery","volume":"16","author":"Cutlar","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2021.113842_b0505","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jconrel.2016.06.014","article-title":"Highly branched poly(\u03b2-amino ester)s for skin gene therapy","volume":"244","author":"Zhou","year":"2016","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0510","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nmat2202","article-title":"Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles","volume":"7","author":"Verma","year":"2008","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2021.113842_b0515","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1021\/nn403069n","article-title":"Effect of polyplex morphology on cellular uptake, intracellular trafficking, and transgene expression","volume":"7","author":"Shi","year":"2013","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.addr.2021.113842_b0520","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2217\/nnm.15.39","article-title":"Enabling cytoplasmic delivery and organelle targeting by surface modification of nanocarriers","volume":"10","author":"Parodi","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2021.113842_b0525","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/exd.12203","article-title":"Keratinocyte cell lines derived from severe generalized recessive Epidermolysis Bullosa patients carrying a highly recurrent COL7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo","volume":"22","author":"Chamorro","year":"2013","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0530","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ymthe.2004.05.016","article-title":"Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo","volume":"10","author":"Woodley","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0535","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1242\/jcs.112.21.3641","article-title":"Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa","volume":"112","author":"Heinonen","year":"1999","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2021.113842_b0540","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2021.113842_b0545","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1357-4310(97)01143-X","article-title":"Therapeutic gene delivery to the skin","volume":"3","author":"Khavari","year":"1997","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.addr.2021.113842_b0550","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejps.2013.05.005","article-title":"Microneedles for intradermal and transdermal drug delivery","volume":"50","author":"Tuan-Mahmood","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2021.113842_b0555","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mt.2009.5","article-title":"Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments","volume":"17","author":"Bodles-Brakhop","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0560","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.2147\/IJN.S174759","article-title":"Recent advances in ultrasound-based transdermal drug delivery","volume":"13","author":"Seah","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2021.113842_b0565","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.022","article-title":"Topical and cutaneous delivery using nanosystems","volume":"247","author":"Roberts","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0570","doi-asserted-by":"crossref","unstructured":"D. Wenzel, J. Bayerl, A. Nystrom, L. Bruckner-Tuderman, A. Meixner, J.M. Penninger, Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa, Sci Transl Med 6 (2014) 264ra165\u2013264ra165.","DOI":"10.1126\/scitranslmed.3010083"},{"key":"10.1016\/j.addr.2021.113842_b0575","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jconrel.2016.09.015","article-title":"Do nanoparticles have a future in dermal drug delivery?","volume":"246","author":"Patzelt","year":"2017","journal-title":"J. Control Release"},{"key":"10.1016\/j.addr.2021.113842_b0580","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0585","doi-asserted-by":"crossref","unstructured":"R.F. Donnelly, T.R.R. Singh, Novel delivery systems for transdermal and intradermal drug delivery. Chichester, UK, John Wiley & Sons, Ltd, 2015. DOI: 10.1002\/9781118734506.","DOI":"10.1002\/9781118734506"},{"key":"10.1016\/j.addr.2021.113842_b0590","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4155\/tde.10.16","article-title":"Challenges and opportunities in dermal\/transdermal delivery","volume":"1","author":"Paudel","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2021.113842_b0595","doi-asserted-by":"crossref","unstructured":"Mohd. Yasir, Som I, Bhatia K: Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci 2012;4:2.","DOI":"10.4103\/0975-7406.92724"},{"key":"10.1016\/j.addr.2021.113842_b0600","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jps.21863","article-title":"Hydration effects on skin microstructure as probed by high-resolution cryo-scanning electron microscopy and mechanistic implications to enhanced transcutaneous delivery of biomacromolecules","volume":"99","author":"Tan","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2021.113842_b0605","first-page":"135","article-title":"Collagen XVIII deposition in the basement membrane zone beneath the newly forming epidermis during wound healing in mice","volume":"73","author":"Maeba","year":"2019","journal-title":"Acta Med. Okayama"},{"key":"10.1016\/j.addr.2021.113842_b0610","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/1523-1747.ep12476939","article-title":"Charge-selective permeability of dermo-epidermal junction: tracer studies with cationic and anionic ferritins","volume":"91","author":"Kazama","year":"1988","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0615","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev.cellbio.22.010305.104357","article-title":"Epidermal stem cells of the skin","volume":"22","author":"Blanpain","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2021.113842_b0620","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nature24753","article-title":"Transgenic stem cells replace skin","volume":"551","author":"Aragona","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.113842_b0625","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/JID.2015.364","article-title":"Lentiviral engineered fibroblasts expressing codon-optimized COL7A1 restore anchoring fibrils in RDEB","volume":"136","author":"Georgiadis","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0630","doi-asserted-by":"crossref","first-page":"1343003","DOI":"10.1142\/S1793984413430034","article-title":"Effects of polymeric nanoparticle surface properties on interaction with brain tumor environment","volume":"03","author":"Mattix","year":"2013","journal-title":"Nano Life"},{"key":"10.1016\/j.addr.2021.113842_b0635","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2021.113842_b0640","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/10717540600814402","article-title":"Pharmacokinetic consequences of pegylation","volume":"13","author":"Hamidi","year":"2006","journal-title":"Drug Deliv"},{"key":"10.1016\/j.addr.2021.113842_b0645","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2021.113842_b0650","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/jgm.382","article-title":"Integrin targeting using RGD-PEI conjugates for in vitro gene transfer","volume":"5","author":"Kunath","year":"2003","journal-title":"J. Gene Med."},{"key":"10.1016\/j.addr.2021.113842_b0655","doi-asserted-by":"crossref","first-page":"28004","DOI":"10.1074\/jbc.273.43.28004","article-title":"Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery","volume":"273","author":"Schaffer","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2021.113842_b0660","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12551-017-0392-1","article-title":"Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer","volume":"10","author":"Ahmadzada","year":"2018","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.addr.2021.113842_b0665","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/gt.2017.5","article-title":"Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems","volume":"24","author":"Guan","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.addr.2021.113842_b0670","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/jid.2010.90","article-title":"Progress in epidermolysis bullosa research: toward treatment and cure","volume":"130","author":"Uitto","year":"2010","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0675","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/nm1504","article-title":"Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells","volume":"12","author":"Mavilio","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2021.113842_b0680","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jid.2016.10.038","article-title":"Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells","volume":"137","author":"Bauer","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0685","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature24487","article-title":"Regeneration of the entire human epidermis using transgenic stem cells","volume":"551","author":"Hirsch","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.addr.2021.113842_b0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.stemcr.2013.11.001","article-title":"Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa","volume":"2","author":"De Rosa","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2021.113842_b0695","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1087-0024.2005.10202.x","article-title":"Clinical and pathological features of pachyonychia congenita","volume":"10","author":"Leachman","year":"2005","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"10.1016\/j.addr.2021.113842_b0700","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.18850","article-title":"Sharing (data) is caring for patients with pachyonychia congenita","volume":"182","author":"Mordaunt","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.addr.2021.113842_b0705","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/mt.2009.273","article-title":"First-in-human mutation-targeted siRNA phase Ib Trial of an inherited skin disorder","volume":"18","author":"Leachman","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2021.113842_b0710","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.det.2018.11.004","article-title":"What\u2019s new in genetic skin diseases","volume":"37","author":"Hill","year":"2019","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.addr.2021.113842_b0715","doi-asserted-by":"crossref","first-page":"604","DOI":"10.24953\/turkjped.2019.04.020","article-title":"Netherton syndrome previously misdiagnosed as hyper IgE syndrome caused by a probable mutation in SPINK5 C","volume":"61","author":"\u00d6zyurt","year":"2019","journal-title":"Turk. J. Pediatr."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21002349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X21002349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:22:32Z","timestamp":1777515752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X21002349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":143,"alternative-id":["S0169409X21002349"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2021.113842","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly branched poly(\u03b2-amino ester)s for gene delivery in hereditary skin diseases","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2021.113842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113842"}}